More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

The number of parenteral drugs in the industry's pipeline and recently approved new drugs continues to rise with the increase of biologics and more complex active pharmaceutical ingredients. DCAT Value Chain Insights examines recent FDA approvals...

The FDA and FTC are collaborating to advance market competition in biologics, including for biosimilars. What have the agencies done thus far and what are they planning to do? The US market for biologics Earlier this month (February 2020), the US...

Cambrex eBook: The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021, driven by positive industry trends — many of which our experts commented on in Part 1 of the Cambrex eBook. Market data shows just how...

Small molecules still lead over biologics in recent drug approvals, accounting for nearly three-fourths of drug approvals over the past several years, but will small molecules' dominance continue? DCAT Value Chain Insights takes an inside...

The UK officially withdrew from the European Union (EU) on January 31 and now has until the end of 2020 to negotiate a trade deal with the EU. How may a trade deal unfold, and what is the impact for the pharmaceutical industry? Inside Brexit: What...

Cambrex experts have contributed more articles to our biggest eBook yet. The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities and employees than ever before. Enjoy Part 1 of our latest Cambrex...

From a more pessimistic macroeconomic view, to uncertainty arising from ongoing trade conflicts, and geopolitical tensions, executives weigh in on key issues that will impact performance in 2020. Taking the pulse To gain a perspective on what is...

The European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents research-based innovator companies, put out a position paper on how to best address drug shortages. This follows reports by both the European Medicines...

With 2020 underway, what are key developments and trends in the pharmaceutical industry that are on the industry's radar for this year? DCAT Value Chain Insights provides its Top 10 Pharma Watch List for 2020. The Top 10 Pharma Watch List for...